800 followers
RT @Miguel_A_Maria: The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Corona…
RT @Miguel_A_Maria: The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Corona…
The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial https://t.co/BxecZV2WtG https://t.co/5NHVQtHqVp